comparemela.com

Page 2 - Uschi Mayer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

/PRNewswire/ Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company s botulinum toxin product, in.

United kingdomCzech republicNew zealandUschi mayerAndreas prinzCroma pharma gmbPrnewswire croma pharmaCroma pharma gmbhCroma pharma

Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company s botulinum toxin product, in 12 additional European markets.

New zealandCzech republicUnited kingdomAndreas prinzCroma pharma gmbUschi mayerCroma pharmaCroma pharma gmbhWirtschaft und finanzenPa ots

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European
presseportal.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from presseportal.de Daily Mail and Mail on Sunday newspapers.

United kingdomCzech republicNew zealandCroma pharmaUschi mayerCroma pharma gmbAndreas prinzCroma pharma gmbh

Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter

Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased marginsGrowth driven by launch of Letybo® and its catalytic effect on the existing

New zealandUschi mayerAndreas prinzPrnewswire croma pharma gmbhCroma pharma gmbWhile the companyPharma gmbhCroma pharma gmbhGefallene big techs

C O R R E C T I O N -- Croma-Pharma

In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised

New zealandAndreas prinzCroma pharma gmbPrnewswire croma pharma gmbhUschi mayerWhile the companyPharma gmbhCroma pharma gmbhGefallene big techs

vimarsana © 2020. All Rights Reserved.